DETECTION OF MINIMAL RESIDUAL BCR/ABL TRANSCRIPTS BY A MODIFIED POLYMERASE CHAIN-REACTION
- 1 September 1988
- journal article
- research article
- Vol. 72 (3) , 893-897
Abstract
The Philadelphia (Ph1) chromosome in chronic myelengenous leukemia (CML) involves reciprocal translocation of the bcr gene and the c-abl oncogene. The fused bcr/abl gene is transcribed into two types of chimeric mRNA. By means of a combined method S1 nuclease protection and polymerase chain reaction, we amplified chimeric bcr/abl message can be detected at a dilution of 1:100.000. We also detected residual chimeric bcr/abl transcripts in the remission samples from tow Ph1-positive CML patients. This technique has the potential to identify a subpopulation of Ph1-positive CML patients in remission who are at high risk of relapse.This publication has 3 references indexed in Scilit:
- The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia.Molecular and Cellular Biology, 1987
- Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused geneCell, 1986
- Marrow Transplantation for the Treatment of Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1986